Knowledge base

The hormonal therapy is used in Patients not qualifying for radical treatment, and is a main conservative treatment method in prostate cancer patients. It is also used as a therapy supplementing the radical treatment during radiotherapy. It eliminates endogenous androgens…

Risk factors for development of benign prostatic hyperplasia The prostate is a hormone-dependent organ - its development depends on hormonal environment controlled by the hypothalamic-pituitary-testicular axis. The established risk factors for BPH include age and presence of androgens secreted by…

International clinical studies Many renowned medical centres all over the world, specialising in diagnostics and treatment of prostate cancer, participate in clinical studies concerning this cancer. Urologists and oncologists at the best medical centres in Europe and the United States…

HIFU method advantages Delayed results for 15 years show high full recovery rates of 83–87%, low level of complications, and maintaining previous quality of patient's life. The HIFU procedure does not put the Patient at a risk of a long…